Axxess Pharma Inc. Announces US Board Certified Cardiologist, Dr. Fred Maese as Senior Consultant
04 September 2013 - 11:00PM
Marketwired
Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical
and nutritional supplements company, is pleased to announce Dr.
Fred Maese, US Board-Certified Cardiologist and a member of the
American College of Cardiology, has joined Axxess Pharma.
Since 1997 Dr. Maese has been practicing adult Cardiology and
Internal Medicine in Dallas, Texas with expertise in general
clinical cardiology, echocardiography and nuclear cardiology. Dr.
Maese also has a large following on his radio shows, which cross
over to the Hispanic network 'Univision.'
Daniel Bagi, M.D., President of Axxess Pharma stated: "Dr. Maese
brings to AXXESS a wealth of knowledge and experience, running a
successful medical practice. He also possesses a strong medical
following via his radio shows. Dr. Maese will be a key component in
the execution of our Business Plan."
Business Acumen: Dr. Maese was instrumental in the clinical
acceptance, widespread use and business models pertaining to the
Lap Band procedure for morbidly obese patients with and without
cardiovascular disease who had failed conservative medical weight
management. Dr. Maese also has significant experience in medical
education in both radio and television, with his segment
"Breakthrough Medicine" receiving an overwhelming acceptance by the
public and peers on the popular show Good Morning Texas. In
addition, his radio shows on Univision (a Hispanic population
targeted TV channel) in Texas have also focused on an educational
format pertinent to the Latin American population. This year he
will launch both English and Spanish weekly radio programming on a
variety of medical and other topics.
Dr. Maese is also the creator of the MyClinic affordable and
convenient primary care model, started in 2011 and now in the
expansion phase. This concept of primary care delivery services
promotes preventive, acute and chronic care strategies for the
whole family in an affordable and convenient fashion. MyClinic is
poised to become a leader in the primary and preventive care
services for the US population over the next three to five
years.
For more information, please visit www.axxesspharmainc.com, or
contact Investor Relations at (973) 351-3868.
About Axxess Pharma Inc.:
Axxess Pharma Inc. is a Nevada Corporation operating through its
wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc.,
headquartered in Toronto. Axxess is a specialty Health Care
Products Company dedicated to improving health and quality of life
by offering select medicines, nutritional supplements and over the
counter remedies all across the Americas. Axxess's goal is to bring
additional products to the market and provide new, innovative
options for better health spanning areas such as high cholesterol,
blood pressure, acute pain, - to optimal health management through
improved nutritional supplements.
Safe Harbor Statement:
Statements about the Company's future expectations and all other
statements in this press release other than historical facts, are
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as that term is defined in the Private Securities
Litigation Reform Act of 1995. The Company intends that such
forward-looking statements be subject to the safe harbors created
thereby.
The above information contains information relating to the
Company that is based on the beliefs of the Company and/or its
management, as well as assumptions made by any information
currently available to the Company or its management. When used in
this document, the words "anticipate," "estimate," "expect,"
"intend," "plans," "projects," and similar expressions, as they
relate to the Company or its management, are intended to identify
forward-looking statements. Such statements reflect the current
view of the Company regarding future events and are subject to
certain risks, uncertainties and assumptions, including the risks
and uncertainties noted. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
to be incorrect, actual results may vary materially from those
described herein as anticipated, believed, estimated, expected,
intended or projected. In each instance, forward-looking
information should be considered in light of the accompanying
meaningful cautionary statements herein. Factors that could cause
results to differ include, but are not limited to, successful
performance of internal plans, the impact of competitive services
and pricing and general economic risks and uncertainties.
Contact: Investor Relations Taylor Capitol, Inc. Stephen Taylor
(973) 351-3868 STEPHTAYL9@AOL.COM www.TheStockAlerts.com
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Jun 2024 to Jul 2024
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Jul 2023 to Jul 2024